Is Exploration of Alternate Immune Pathways Needed in Hidradenitis Suppurativa? A Case of Atopic Dermatitis and Concurrent Hidradenitis Suppurativa Responding to Dupilumab
Hidradenitis suppurativa (HS) is an inflammatory dermatosis associated with overactive T helper 1/T helper 17 (Th1/Th17) cells.HS has been effectively treated with biologic medications; however, many such biologics lack large randomized controlled trials.Only one such biologic, adalimumab, has been approved quest fryer by the US Food and Drug Admin